Skip to main content

Want a detailed portfolio tracker?

Exicure (XCUR) P/E (2018 - 2026)

Exicure (XCUR) P/E from May 22, 2018 to Jul 21, 2026. The TTM Exicure (XCUR) P/E is -6.72. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Exicure (XCUR)

YearP/EChange
2026-6.72-43.57%
2025-11.91+3.82%
2024-11.47+140.47%
2023-4.77-68.22%
2022-15.02-81.03%
2021-79.17-88.58%
2020-693.35-38.11%
2019-1.12K+12.97%
2018-991.75N/A

Comparison Exicure (XCUR) P/E with competitors

Exicure (XCUR) P/E is -6.72.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.11%
FGENFibroGen Inc0.24-103.57%
CHRSCoherus Biosciences Inc0.85-112.62%
FBIOFortress Biotech Inc0.95-114.12%
ORMPOramed Pharmaceuticals Inc1.50-122.36%
AGENAgenus Inc3.01-144.77%
INVAInnoviva Inc3.15-146.92%
VXRTVaxart Inc3.55-152.80%
CRMDCorMedix Inc3.63-153.97%
CVACCureVac N.V.4.45-166.13%
GLPGGalapagos NV4.86-172.28%
SRPTSarepta Therapeutics Inc4.88-172.62%
ABEOAbeona Therapeutics Inc5.39-180.14%
ABUSArbutus Biopharma Corp5.60-183.24%
ZVRAZevra Therapeutics Inc5.89-187.58%
SPROSpero Therapeutics Inc6.23-192.65%
CGENCompugen Ltd6.31-193.92%
RIGLRigel Pharmaceuticals6.87-202.23%
SLXNSilexion Therapeutics Corp7.30-208.53%
OMEROmeros Corporation9.26-237.73%
AUPHAurinia Pharmaceuticals Inc9.58-242.58%
PLXProtalix BioTherapeutics Inc10.89-262.01%
ACADAcadia Pharmaceuticals Inc11.73-274.47%
TBPHTheravance Biopharma Inc12.26-282.41%
ADMAAdma Biologics Inc12.42-284.73%
HRMYHarmony Biosciences Holdings Inc13.82-305.58%
SABSSAB Biotherapeutics Inc14.14-310.28%
NAGENiagen Bioscience Inc14.82-320.43%
INCYIncyte Corp15.82-335.37%
REGNRegeneron Pharmaceuticals Inc15.86-335.88%
PBYIPuma Biotechnology Inc17.32-357.58%
CPRXCatalyst Pharmaceuticals Inc17.44-359.42%
EXELExelixis Inc17.54-360.89%
TGTXTG Therapeutics Inc18.97-382.13%
MDXGMimedx Group Inc20.55-405.73%
XOMAXOMA Royalty Corp22.87-440.28%
ARGXArgen X SE24.30-461.46%
CTMXCytomX Therapeutics Inc24.82-469.24%
XOMAOXOMA Royalty Corp25.34-477.03%
HALOHalozyme Therapeutics Inc25.62-481.18%
XOMAPXOMA Royalty Corp25.67-481.87%
VRTXVertex Pharmaceuticals Inc27.99-516.45%
RPRXRoyalty Pharma plc - Class A28.69-526.75%
SLNOSoleno Therapeutics Inc29.02-531.63%
ASNDAscendis Pharma A/S30.09-547.55%
LGNDLigand Pharmaceuticals Inc - Class B37.91-663.98%
APLSApellis Pharmaceuticals Inc39.02-680.48%
BMRNBiomarin Pharmaceutical Inc42.21-727.94%
KRYSKrystal Biotech Inc45.34-774.53%
ONCBeiGene Ltd69.54-1134.48%
PHARPharming Group N.V.75.03-1216.08%
TECHBio-Techne Corp101.96-1616.73%
VCELVericel Corp109.92-1735.18%
ALNYAlnylam Pharmaceuticals Inc117.96-1854.84%
GMABGenmab140.29-2186.96%
TLXTelix Pharmaceuticals Ltd162.15-2512.17%
CORTCorcept Therapeutics Inc212.86-3266.45%